DNA binding chelates for nonviral gene delivery imaging

Area of Science:

• Biomedical Imaging
• Molecular Biology
• Drug Delivery Systems

Background:

• Noninvasive monitoring of gene delivery is crucial for understanding vector biodistribution and kinetics.
• Current methods lack the resolution and real-time tracking capabilities needed for effective gene therapy assessment.

Purpose of the Study:

• To develop and validate a novel approach for noninvasive in vivo imaging of gene delivery using peptide-based chelates (PBC).
• To assess the biodistribution and kinetics of gene vectors, including "naked" DNA and lipoplexes, using the developed imaging technique.

Main Methods:

• Development of heterobifunctional peptide-based chelates (PBC) with DNA-binding and technetium-binding properties.
• Labeling of PBC with technetium-99m ((99m)Tc) for nuclear imaging.
• In vivo imaging studies in mice using (99m)Tc-labeled PBC-DNA and lipoplexes, followed by biodistribution analysis and gene expression validation.

Main Results:

• The (99m)Tc-labeled PBC successfully bound to double-stranded DNA upon UV irradiation.
• Nuclear imaging revealed distinct biodistribution patterns for (99m)Tc PBC-labeled DNA and lipoplexes.
• Lipoplexes showed slower elimination from the injection site compared to naked DNA, correlating with higher gene expression.

Conclusions:

• The developed (99m)Tc-labeled PBC approach enables noninvasive in vivo monitoring of gene delivery.
• This technique provides valuable insights into the biodistribution and kinetics of gene vectors.
• The findings support the use of this imaging method for optimizing gene therapy strategies.